Dexcom stock price traded at $125.30 today, with volume 20% above the 30-day average, reflecting heightened market interest. Analysts project EPS growth of 18% for FY2024, reinforcing the bullish case. Cryptocurrency-exposed stocks are climbing today, with the price of Bitcoin up more than +2% at a 1.5-week high. As a result, Coinbase Global (COIN), Galaxy Digital (GLXY), MARA Holdings (MARA), and Strategy (MSTR) are up more than +3%. DexCom’s shares are somewhat volatile and have had 14 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. Dexcom’s $125 stock price today signals steady demand as the firm remains a top healthcare growth pick among investment banks, reinforced by consistent earnings surprises.
